Work

Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations

Year: 2008

Type: review

Source: Drug Resistance Updates

DOI: 10.1016/j.drup.2007.11.003

Authors: Jaclyn LoPiccolo, Gideon M. Blumenthal, Wendy B. Bernstein, Phillip A. Dennis

Institutions: National Cancer Institute, Center for Cancer Research

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Award: Development of Akt Inhibitors

OpenAlex ID: W2074433596

FWCI: 4.943

Cites: 249

Cited by: 808

Related to: 10